September 22, 2022 Experience InnoCare Pharma RMB2.9 billion Shanghai IPO This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
September 21, 2022 Experience Nayax direct listing The shares are listed on the Nasdaq Global Select Market
September 21, 2022 Experience Tencent Music Entertainment Group secondary listing We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
September 21, 2022 Experience Toyota Motor Credit $2.25 billion notes offering We advised the company on the SEC-registered notes offering
September 21, 2022 Experience Allakos $150 million follow-on offering The shares are listed on the Nasdaq Global Select Market
September 21, 2022 Experience Medtronic Global Holdings €3.5 billion notes offering The investment-grade notes were issued in four tranches
September 20, 2022 Experience CrowdStrike Holdings acquisition of Reposify We are advising CrowdStrike on the transaction
September 20, 2022 Experience Pon sale of interest in Hiller to Littlejohn & Co. We advised Pon on the transaction
September 20, 2022 Experience Alignment Healthcare $132.75 million secondary offering The shares are listed on the Nasdaq Global Select Market
September 19, 2022 Experience Roivant Sciences $400 million at-the-market offering We advised the company on an SEC-registered at-the-market offering